|
|
Volumn 11, Issue 3, 2015, Pages e442-e444
|
|
Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTICOAGULANT AGENT;
FIBRINOLYTIC AGENT;
BLOOD;
COMPLICATION;
HUMAN;
NEOPLASMS;
PATIENT SELECTION;
PRACTICE GUIDELINE;
RISK ASSESSMENT;
RISK FACTOR;
TREATMENT OUTCOME;
VENOUS THROMBOEMBOLISM;
ANTICOAGULANTS;
FIBRINOLYTIC AGENTS;
HUMANS;
NEOPLASMS;
PATIENT SELECTION;
RISK ASSESSMENT;
RISK FACTORS;
TREATMENT OUTCOME;
VENOUS THROMBOEMBOLISM;
|
|
EID: 84983056976
PISSN: None
EISSN: 1935469X
Source Type: Journal
DOI: 10.1200/JOP.2015.004473 Document Type: Article |
|
Times cited : (113)
|
|
References (0)
|